Abstract
Background. Non-oncological radiotherapy is not very common among radiotherapy centers and is often unknown to other specialists. The advantages of this method are ease of use and the possibility of using it in outpatient settings, which ensures its high cost-effectiveness. The use of radiotherapy in patients with non-tumor diseases often makes it possible not only to reduce the dose of anti-inflammatory and analgesic drugs, but also to improve the quality of life in general. For the most part, the underestimation of radiotherapy for benign conditions is associated with insufficient awareness of doctors about the possibilities and results of treatment and a clear exaggeration of the danger of developing possible radiation damage, adverse long-term genetic and somatic consequences when using it, as well as the introduction into healthcare practice of numerous effective medications, although not always safe for the patientʼs body in terms of the development of side effects. Purpose – analysis and synthesis of current data on radiotherapy for non-tumor diseases with the popularization of information among the medical community. Materials and Methods. In-depth analysis of full-text scientific publications available in the modern information space over the last 10 years. Results. The authors conducted a thorough analysis of the modern literature on radiation therapy for non-oncological conditions and diseases. Unfounded distrust of radiation therapy for non-neoplastic diseases led to a misunderstanding of the importance of this method, the benefits of which are much higher than the possibility of harmful effects calculated using hypotheses and extrapolations. The effectiveness of radiation therapy for non-neoplastic diseases is explained by the anti-inflammatory, analgesic, desensitizing, antispastic and antisecretory effects of ionizing radiation. Typically, a single focal dose (SFD) is 0.3–0.5–0.7 Gy, the total focal dose (TFD) is 4–6 Gy with an irradiation rhythm of 3 times a week (every other day). At the initial stage of the inflammatory process, irradiation can lead to its cessation, which is manifested in a decrease in pain, the disappearance of edema and tissue infiltration. Some patients may experience an initial short-term exacerbation of the inflammatory reaction. Conclusions. It is undisputed that the main area of application of radiotherapy in the near future will remain oncology. However, the picture of the use of ionizing radiation in medicine would be far from complete if radiotherapy of non-tumor diseases were left without due attention. Therefore, non-oncological radiotherapy requires further research and use in clinical practice.

This publication has 26 references indexed in Scilit: